News iRhythm digital heart monitoring service backed by NICE A heart monitor developed by iRhythm has become the first product to be endorsed by NICE in a pilot project covering digital health technologies.
Partner Content Partner Content Patient Monitoring Devices Market will grow at 5% CAGR betwe... Patient Monitoring Devices Market worth $27bn by 2025
News Ambros' $125m for pain disorder drug, and other financings Our latest crop of biofinancings has nine-figure rounds for Ambros, Atavistik, Orum, and Addition, with Link Cell and Aeovian also raising new funds.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.